摘要
2017年11月14日,美国心脏病学学会(American College of Cardiology,ACC)、美国心脏协会(American Heart Association,AHA)联合其他9大民间权威机构,发布了2017年版《美国成人高血压防治指南》(2017ACC/AHA).该版指南重新划分了高血压阈值,设置了新的降压目标值,而不再延续执行先前已颁布10余年的高血压诊断标准.该指南一经发布,就引起了全球范围的关注和争议,后续所带来的冲击更是不容小觑.结合中国高血压现状对该指南进行初步解读.
On November 14,2017,American College of Cardiology(ACC)and American Heart Association(AHA),together with 9 other authorities,released 2017 American Guideline for Hypertension in Adults(2017ACC/AHA).The guideline no longer used the past diagnostic standard of hypertension,and it set up a new antihypertensive target.Ever since the issue of the guideline,experts and researchers around the world have been debating over the pros and cons of the new changes the guideline contains,and it can be expected that this guideline will continue to remain a controversial topic.This paper is an attempt to interpret the American guideline by taking into account the present situation in China.
作者
潘新
徐亚伟
徐大春
PAN Xin;XU Yawei;XU Dachun(Department of Cardiology,Shanghai Tenth People’s Hospital,Tongji University,Shanghai 200072,China)
出处
《上海大学学报（自然科学版）》
CAS
CSCD
北大核心
2018年第3期331-335,共5页
Journal of Shanghai University:Natural Science Edition
基金
国家自然科学基金资助项目(81270194
81770391)
关键词
高血压
指南
解读
hypertension
guideline
interpretation
